RT @Super1NYC: #Premarket Top % Gainers: $SNY 8%, $BHI 7%, $MRVL 6%, $JDST $WLL $STM $BIDU $HUN $YNDX $WFT $NVAX $DGAZ $TVIX $RWLK $ZTO $DW…
RT @Super1NYC: #Premarket Top % Gainers: $SNY 7%, $MRVL 6%, $BHI 6%, $JDST 3%, $TVIX $GEF $WLL $LUX $UVXY $STM $RWLK $SQQQ $OCN $ZTO $FMS $…
#Premarket Top % Gainers: $SNY 8%, $BHI 7%, $MRVL 6%, $JDST $WLL $STM $BIDU $HUN $YNDX $WFT $NVAX $DGAZ $TVIX $RWLK $ZTO $DWTI $UVXY $BTI
Premarket Top % Gainers: $SNY 7%, $MRVL 6%, $BHI 6%, $JDST 3%, $TVIX $GEF $WLL $LUX $UVXY $STM $RWLK $SQQQ $OCN $ZTO $FMS $GOOG $TWTR $VXX
RT @Super1NYC: #Premarket Top % Gainers: $SNY 7%, $MRVL 6%, $BHI 6%, $JDST 3%, $TVIX $GEF $WLL $LUX $UVXY $STM $RWLK $SQQQ $OCN $ZTO $FMS $…
#Premarket Top % Gainers: $SNY 7%, $MRVL 6%, $BHI 6%, $JDST 3%, $TVIX $GEF $WLL $LUX $UVXY $STM $RWLK $SQQQ $OCN $ZTO $FMS $GOOG $TWTR $VXX
Stocks in play viernes 28 de octubre 2016:
$AAPL $FB $TWTR $BABA $BIDU $XOM $CYH $MRVL $AMGN $CEMP $GT $SNY $ABBV… https://t.co/YMyVIg0Yqb
Stocks in play viernes 28 de octubre 2016:
$AAPL $FB $TWTR $BABA $BIDU $XOM $CYH $MRVL $AMGN $CEMP $GT $SNY... https://t.co/GPHTEJjX8q
RT @AndyBiotech: "Manufacturing issues" the words of the day, such a black box
$REGN $SNY
https://t.co/I6Cnq3t9JS
$AERI
https://t.co/laMb…
RT @AndyBiotech: "Manufacturing issues" the words of the day, such a black box
$REGN $SNY
https://t.co/I6Cnq3t9JS
$AERI
https://t.co/laMb…
RT @AndyBiotech: "Manufacturing issues" the words of the day, such a black box
$REGN $SNY
https://t.co/I6Cnq3t9JS
$AERI
https://t.co/laMb…
Benzinga: 18 Stocks Moving In Friday's PreMarket https://t.co/joQofuG9vX $AMZN $BGS $GNCA $SNY $CRUS $MRVL $GRPN $GOOG $CEMP $NVO $MCK $CA…
Benzinga: 18 Stocks Moving In Friday's PreMarket https://t.co/CVBbQT1JXg $AMZN $BGS $GNCA $SNY $CRUS $MRVL $GRPN $GOOG $CEMP $NVO $MCK $CA…
18 Stocks Moving In Friday's PreMarket https://t.co/PAWij7NW3N $AMZN $BGS $GNCA $SNY $CRUS $MRVL $GRPN $GOOG $CEMP $NVO $MCK $CAH $MLNX $CYH
RT @AndyBiotech: "Manufacturing issues" the words of the day, such a black box
$REGN $SNY
https://t.co/I6Cnq3t9JS
$AERI
https://t.co/laMb…
RT @AndyBiotech: "Manufacturing issues" the words of the day, such a black box
$REGN $SNY
https://t.co/I6Cnq3t9JS
$AERI
https://t.co/laMb…
RT @AndyBiotech: "Manufacturing issues" the words of the day, such a black box
$REGN $SNY
https://t.co/I6Cnq3t9JS
$AERI
https://t.co/laMb…
RT @AndyBiotech: "Manufacturing issues" the words of the day, such a black box
$REGN $SNY
https://t.co/I6Cnq3t9JS
$AERI
https://t.co/laMb…
RT @AndyBiotech: "Manufacturing issues" the words of the day, such a black box
$REGN $SNY
https://t.co/I6Cnq3t9JS
$AERI
https://t.co/laMb…
"Manufacturing issues" the words of the day, such a black box
$REGN $SNY
https://t.co/I6Cnq3t9JS
$AERI… https://t.co/eSjAfeIiy7
Premarket Top % Gainers: $SNY 7%, $MRVL 6%, $BHI 6%, $JDST 3%, $TVIX $GEF $WLL $LUX $UVXY $STM $RWLK $SQQQ #stocks #investing #tradeideas
Premarket Top % Gainers: $SNY 7%, $MRVL 6%, $BHI 6%, $JDST 3%, $TVIX $GEF $WLL $LUX $UVXY $STM $RWLK $SQQQ #stocks #investing #tradeideas
RT @LargeVoidBot: Popular: $BIDU, $ABBV, $SNY, $NUGT, $VTR, $MDY, $JDST, $NWL, $EMN, $SRCL, $WETF
Popular: $BIDU, $ABBV, $SNY, $NUGT, $VTR, $MDY, $JDST, $NWL, $EMN, $SRCL, $WETF
EARLY MOVERS: $AMZN $GOOG $GOOGL $BHI $MCK $HSY $UBS $NVO $SNY $BUD $XRX $NWL $AMGN $AAPL $CMG - CNBC https://t.co/LVWiwntAru
EARLY MOVERS: $AMZN $GOOG $GOOGL $BHI $MCK $HSY $UBS $NVO $SNY $BUD $XRX $NWL $AMGN $AAPL $CMG - CNBC https://t.co/KR33Pv03km
RT @eWhispers: Friday #earnings $XOM $MA $ABBV $CVX $RCL $NWL $BUD $GT $SHPG $PSX $HSY $XRX $NVO $SNY $IMGN $WETF $COG $AN $WY $CPN https:/…
RT @eWhispers: Friday #earnings $XOM $MA $ABBV $CVX $RCL $NWL $BUD $GT $SHPG $PSX $HSY $XRX $NVO $SNY $IMGN $WETF $COG $AN $WY $CPN https:/…
RT @eWhispers: Friday #earnings $XOM $MA $ABBV $CVX $RCL $NWL $BUD $GT $SHPG $PSX $HSY $XRX $NVO $SNY $IMGN $WETF $COG $AN $WY $CPN https:/…
RT @TradeOutLoud: Friday #earnings $XOM $MA $ABBV $CVX $RCL $NWL $BUD $GE $SHPG $PSX $HSY $XRX $NVO $SNY $IMGN $WETF $COG $AN $WY $CPN http…
Mylan NV (MYL) Stock Holders Can Shrug Off Kaleo’s EpiPen Threat https://t.co/pYNnjZfs98 $MYL $SNY #epipen… https://t.co/SFxZiGcTJw
Mylan NV (MYL) Stock Holders Can Shrug Off Kaleo’s EpiPen Threat https://t.co/b769jObTUr $MYL $SNY #epipen… https://t.co/RioTqO3u6E
$SNY hot on social media now, but analyzed at ChartMill everyday https://t.co/0IlveKHTam #equitycrowdfunding #Halloween
RT @BosBizDon: BREAKING: FDA approval could be delayed for Sanofi Genzyme’s next blockbuster $sny https://t.co/zzjz0cRoZT
Premarket Top % Gainers: $GNCA 14%, $BHI 7%, $SNY 7%, $CRUS 6%, $HBI $FV $RCL $DUST $STM $OCN $JDST $CYH #stocks #investing #tradeideas
Recent $SNY technical alerts: Slingshot Bearish plus 4 more alerts... https://t.co/NqoERuxMwv
It's not #about the #wrong #decision or the #right decision but #more about the #best decision. $CRUS $BIDU $GOOGL $EXPE $SNY $HSY $MA $NOW
RT @Super1NYC: #Premarket Top % Gainers: $GNCA 14%, $BHI 7%, $SNY 7%, $CRUS 6%, $HBI $FV $RCL $DUST $STM $OCN $JDST $CYH $MRVL $NAK $BIDU…
RT @sanofi: #Sanofi Q3 2016 financial results announced today! For more info: https://t.co/xd7AiIHaNe $SNY #infographic https://t.co/Dnfwxh…
Dropping $SNY call and going to $ABBV. #thedayofathosandresults
#Premarket Top % Gainers: $GNCA 14%, $BHI 7%, $SNY 7%, $CRUS 6%, $HBI $FV $RCL $DUST $STM $OCN $JDST $CYH $MRVL $NAK $BIDU $CY $CXRX $NOW
Why These Stocks Are Up https://t.co/JaxemEjywN $LC $LVLT $LOGM $MRVL $QCOM $RCL $SNY $SGEN $SRCL $SMCI $TWTR $VRSN $WLL
Pre-market movers $GNCA $BHI $SNY $CRUS $HBI $RCL $MRVL $CY $GRPN $BIDU $NCLH $RWLK
RT @sanofi: #Sanofi Q3 2016 financial results announced today! For more info: https://t.co/xd7AiIHaNe $SNY #infographic https://t.co/Dnfwxh…
pre market $SNY UP $MRVL UP $GOOG UP
@ $QQQ $SPY $XBI
RT @sanofi: #Sanofi Q3 2016 financial results announced today! For more info: https://t.co/xd7AiIHaNe $SNY #infographic https://t.co/Dnfwxh…
Unicorn Bay rating for $SNY is 4.12 out of 5. https://t.co/5zHnG98N64
RT @sanofi: Press Release: Sanofi $SNY publishes Q3 financial results https://t.co/lfkcG1HGqn
RT @sanofi: #Sanofi CEO Olivier Brandicourt comments on the positive Q3 financial results revealed today $SNY https://t.co/VsdBbxKLxs
I wonder if there's gloating in Paris right now that is audible in Copenhagen. "Who's having a bad Q3 now?" $NVO $SNY
RT @sanofi: #Sanofi CEO Olivier Brandicourt comments on the positive Q3 financial results revealed today $SNY https://t.co/VsdBbxKLxs
RT @sanofi: #Sanofi Q3 2016 financial results announced today! For more info: https://t.co/xd7AiIHaNe $SNY #infographic https://t.co/Dnfwxh…
RT @SanofiUS: #Sanofi Q3 2016 Earnings Results announced today. For more info: https://t.co/CutIxtuqnQ $SNY #infographic https://t.co/G1fry…
#Sanofi Q3 2016 Earnings Results announced today. For more info: https://t.co/CutIxtuqnQ $SNY #infographic https://t.co/G1fryiEKLf
$SNY up 8.05% at $40.25 in pre-market,lifts its profit outlook for the year & detailing news of a big share buyback https://t.co/GhV659aEZD
$SNY:
3 Stocks to Avoid in Biotech:
https://t.co/qgYovJ7o5P
$REGN Regeneron says manufacturing deficiencies at Sanofi site could potentially delay pending FDA OK https://t.co/Y9PEffLIZg $REGN $SNY
RT @AKAarsalan: Sanofi has a lot riding on the approval of sarilumab. https://t.co/muPlRXhDvy $SNY $REGN
#FDA flashes red light on $SNY manufacturing infraction, threatening a looming blockbuster decision
https://t.co/RgMGpMq0LM
$REGN $SNY:
Regeneron says manufacturing deficiencies at Sanofi site could …:
https://t.co/nUkikjQRkg
RT @AKAarsalan: Sanofi has a lot riding on the approval of sarilumab. https://t.co/muPlRXhDvy $SNY $REGN
RT @AKAarsalan: Sanofi has a lot riding on the approval of sarilumab. https://t.co/muPlRXhDvy $SNY $REGN
Regeneron says manufacturing deficiencies at Sanofi site could potentially delay pending FD... https://t.co/KlsgpQlRVC #premarket $REGN $SNY
Regeneron says manufacturing deficiencies at Sanofi site could potentially delay pending FD... https://t.co/IyxauzFCL7 #premarket $REGN $SNY
RT @fwpharma: Sanofi lifts annual earnings guidance after Q3 sales, profit rise https://t.co/wtAt9wgPVe $SNY
Sanofi has a lot riding on the approval of sarilumab. https://t.co/muPlRXhDvy $SNY $REGN
RT @BosBizDon: BREAKING: FDA approval could be delayed for Sanofi Genzyme’s next blockbuster $sny https://t.co/zzjz0cRoZT
Sanofi Lifts Profit Outlook - WSJ $SNY $REGN https://t.co/ryRSsBOI2o
RT @sanofi: #Sanofi Q3 2016 financial results announced today! For more info: https://t.co/xd7AiIHaNe $SNY #infographic https://t.co/Dnfwxh…
$SNY:
FDA approval could be delayed for Sanofi Genzyme’s next blockbuster:
https://t.co/zky1DHE2uZ
$CRUS is up nicely in pre market https://t.co/tHal6opK5o #Stocks $BHI $MRVL $SNY
RT @BosBizDon: BREAKING: FDA approval could be delayed for Sanofi Genzyme’s next blockbuster $sny https://t.co/zzjz0cRoZT
RT @BioStocks: $REGN Advised By $SNY of Manufacturing Deficiencies Raised By FDA During Inspection
https://t.co/WLbiMcJIbP
RT @BioStocks: $REGN Advised By $SNY of Manufacturing Deficiencies Raised By FDA During Inspection
https://t.co/WLbiMcJIbP
$SNY is up +7.7% in premarket trading. The 18-Nov-16 option ATM straddle is implying a move of ±4.5% by expiration. https://t.co/nFhMgwMB6I
#Sanofi Q3 2016 financial results announced today! For more info: https://t.co/xd7AiIHaNe $SNY #infographic https://t.co/Dnfwxh431F
RT @BosBizDon: BREAKING: FDA approval could be delayed for Sanofi Genzyme’s next blockbuster $sny https://t.co/zzjz0cRoZT
RT @BioStocks: $REGN Advised By $SNY of Manufacturing Deficiencies Raised By FDA During Inspection
https://t.co/WLbiMcJIbP
Sanofi Q3 top line up 3%; rare disease product sales up 14%; net income up 3%; shares up 8% prema... https://t.co/3qYfXQpN03 #premarket $SNY
Sanofi Q3 top line up 3%; rare disease product sales up 14%; net income up 3%; shares up 8% prema... https://t.co/5WYp1uFFdD #premarket $SNY
Sanofi Q3 top line up 3%; rare disease product sales up 14%; net income up 3%; shares up 8% prema... https://t.co/PIgn6falcT #premarket $SNY
BREAKING: FDA approval could be delayed for Sanofi Genzyme’s next blockbuster $sny https://t.co/zzjz0cRoZT
$REGN: Deficiencies at $SNY plant involve fill & finish, including for #sarilumab; no #FDA Form 483; Oct 30 sarilum… https://t.co/RN9vFmirL9
$SNY $BHI $MRVL $GEF $CYH $WLL $LUX $YNDX $STM $RWLK $QCOM $FMS stocks percentage higher #Premarket trading https://t.co/x4xtTyrWPg
RT @BioStocks: $REGN Advised By $SNY of Manufacturing Deficiencies Raised By FDA During Inspection
https://t.co/WLbiMcJIbP
Leerink Swann Weighs in on Sanofi’s Q3 2016 Earnings $SNY https://t.co/Au5FK6tK95
RT @sanofi: #Sanofi CEO Olivier Brandicourt comments on the positive Q3 financial results revealed today $SNY https://t.co/VsdBbxKLxs
$SNY:
Sanofi (SNY) Tops Q3 EPS Views; Boosts EPS Outlook; Approves …:
https://t.co/uEZvdbMECm
$SNY CFO Interview - Q3 2016 Results (Video) https://t.co/D753Ff35Sy
$REGN Advised By $SNY of Manufacturing Deficiencies Raised By FDA During Inspection
https://t.co/WLbiMcJIbP
RT @sanofi: Press Release: Sanofi $SNY publishes Q3 financial results https://t.co/lfkcG1HGqn
$SNY announces EUR 3.5B share repurchase program
RT @sanofi: #Sanofi CEO Olivier Brandicourt comments on the positive Q3 financial results revealed today $SNY https://t.co/VsdBbxKLxs
RT @sanofi: Press Release: Sanofi $SNY publishes Q3 financial results https://t.co/lfkcG1HGqn
RT @sanofi: #Sanofi CEO Olivier Brandicourt comments on the positive Q3 financial results revealed today $SNY https://t.co/VsdBbxKLxs
#Sanofi CEO Olivier Brandicourt comments on the positive Q3 financial results revealed today $SNY https://t.co/VsdBbxKLxs
$SNY: Sanofi beats by EUR0.25, beats on revs; raises FY16 EPS above consensus; initiates a EUR3.5 billion share... https://t.co/THHnNQy20p
RT @sanofi: Press Release: Sanofi $SNY publishes Q3 financial results https://t.co/lfkcG1HGqn
$SNY:
European earnings roundup:
https://t.co/aetTMSV5Fx
RT @fwpharma: Sanofi lifts annual earnings guidance after Q3 sales, profit rise https://t.co/wtAt9wgPVe $SNY
Sanofi lifts annual earnings guidance after Q3 sales, profit rise https://t.co/wtAt9wgPVe $SNY
MarketCurrents: European earnings roundup https://t.co/HuG46J9QGi $NVO $SNY $UBS $RBS
$SNY $BUD:
European earnings roundup:
https://t.co/swUfYQeMAj
European earnings roundup https://t.co/DeUShbIt53 $NVO $SNY $UBS $RBS
RT @HomeDayTrading: Stocks in play viernes 28 de octubre 2016:
$AAPL $FB $TWTR $BABA $BIDU $XOM $CYH $MRVL $AMGN $CEMP $GT $SNY $ABBV $BHI…
Up Gappers $GNCA $BHI $SNY $CRUS $HBI $RCL $STM $CYH $OCN $GRPN $MRVL $CXRX $CY $LC $DNAI $BIDU $NOW $SPY #SPX $SPX… https://t.co/zvmUI3btay